Fundraising Fox

Solstice Oncology

Boston, US · Founded 2026 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

DF
David FeltquateExecutive
MK
Maiken Keson-BrookesExecutive
CL
CAROLINE LOEWNamed on SEC filing

Board

ALANDREW LEVIN
ANDREW LEVINBoard directorPartner at RA Capital
JGJULIE GRANT
JULIE GRANTin𝕏Board directorGeneral Partner at Canaan Partners
EMEMILY MINKOW
EMILY MINKOWinBoard directorVenture Partner at RA Capital
MH
MORGAN HALLERBoard director

Investors · 2

Canaan PartnersreportedStamford · $500K – $20Mvia Julie Grant · board
RA CapitalreportedBostonvia Emily Minkow · board

Reported raises · per SEC filings

Form D private placements

$121.3M disclosed across 1 round · 2026

▶$121.3MraisedMar 2026 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David FeltquateExecutive Officer
  • ANDREW LEVINDirector
  • JULIE GRANTDirector
  • EMILY MINKOWDirector
  • MORGAN HALLERDirector
  • Maiken Keson-BrookesExecutive Officer
  • CAROLINE LOEWExecutive Officer, Director, Promoter
Offering amount
$298.4M
Amount sold
$121.3M
First sale
Feb 2026
Incorporated
Corporation, Delaware, 2026
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Solstice Oncology's investors?
Solstice Oncology's investors include Canaan Partners, RA Capital.
How much funding has Solstice Oncology raised?
Solstice Oncology has disclosed $121.3M raised across 1 round.
Where is Solstice Oncology headquartered?
Solstice Oncology is headquartered in Boston, US.